Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
304
-
Total 13F shares, excl. options
-
234M
-
Shares change
-
-9.08M
-
Total reported value, excl. options
-
$4.15B
-
Value change
-
-$195M
-
Put/Call ratio
-
0.42
-
Number of buys
-
171
-
Number of sells
-
-120
-
Price
-
$17.72
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q3 2018
378 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2018.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 304 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 234M shares
of 274M outstanding shares and own 85.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (30.1M shares), Vanguard Group Inc (26.5M shares), FMR LLC (24.6M shares), Meditor Group Ltd (16M shares), STATE STREET CORP (11.3M shares), Matrix Capital Management Company, LP (10M shares), GOLDMAN SACHS GROUP INC (6.5M shares), JPMORGAN CHASE & CO (5.93M shares), MERIAN GLOBAL INVESTORS (UK) Ltd (4.67M shares), and FIRST TRUST ADVISORS LP (4.64M shares).
This table shows the top 304 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.